Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension

NCT03554291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Right Heart Failure

Interventions

DRUG: Famotidine 20 MG
OTHER: Placebo

Sponsor

University of Washington

Collaborators

[object Object]